Clinical Trial Update: Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation [NA]

View source ↗

Summary

A completed clinical trial evaluated a conditioning regimen of fludarabine, cyclophosphamide, and alemtuzumab for patients with recurrent or metastatic renal ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• CAMPATH (ALEMTUZUMAB)
• Cytoxan (cyclophosphamide)
• Fludara (fludarabine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Kidney Cancer | NA | Status: COMPLETED